Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

May 2011

Dental News Roundup May 2011 BY LAUREN UZDIENSKI, MAY 31, 2011

Astra Tech bids due next week . . . Nobel Biocare reportedly interested in Camlog . . . Align announces Cadent interoperability . . . NIH appoints director of the National Institute of Dental and Craniofacial Research . . . Straumann names CFO more

Musculoskeletal News Roundup 26-May-11 BY LAUREN UZDIENSKI, MAY 26, 2011

MDT announces F4Q:11 earnings . . . SYK receives 510(k) clearance for ShapeMatch Cutting Guides . . . Interventional Spine announces first use of the PerX360 System . . . Tornier launches Porous Coated Affiniti Stem for shoulder . . . Smith & Nephew signs distribution agreement with Graftys more

Infuse Linked to Infertility in Men BY LAUREN UZDIENSKI, MAY 25, 2011

A retrospective review of Medtronic's Infuse study published in the Spine Journal this week showed a correlation between male patients treated with Infuse and sterility. Medtronic and the surgeon investigators in the study attributed the side effect to surgeon technique and not Infuse itself, which is why it had generally been excluded in previously published studies. more

Kensey Nash Buys Norian from Synthes BY LAUREN UZDIENSKI, MAY 24, 2011

Kensey Nash paid $22 million to acquire the assets of Synthes' Norian subsidiary. The deal includes an R&D agreement, a supply agreement and the acquisition of a manufacturing facility. The divestiture was a condition of Synthes' settlement with the government over allegations that the company facilitated unauthorized clinical studies of Norian XR, a bone graft substitute. more

Rural Patients More Likely to Undergo Surgery BY LAUREN UZDIENSKI, MAY 24, 2011

Researchers at the Texas Tech University Health Sciences Center were surprised to discover that Medicare patients in rural areas were more likely to undergo a variety of surgical procedures compared with their urban counterparts. The results of the new study, published this month in the Archives of Surgery, may challenge the idea that patients in urban areas have better access to care, but questions remain unanswered about surgical outcomes, whether patients are getting surgery they don't need or the overall health of patients in rural areas. more

Integra LifeSciences Acquires SeaSpine for $89M BY LAUREN UZDIENSKI, MAY 24, 2011

Integra LifeSciences acquired SeaSpine for $89 million in cash, about 1.8x the company's 2010 sales. The company says the transaction offers scale in spine and doubles Integra's distribution footprint and customer base in the U.S. spine hardware market. more

Musculoskeletal News Roundup 19-May-11 BY LAUREN UZDIENSKI, MAY 19, 2011

China Kanghui announces 1Q:11 earnings . . . Premia Spine acquires Impliant assets . . . Ortho Space raises $3M . . . Medtronic launches Kyphon Xpede Bone Cement . . . dr7 to collaborate with Biomet on rotator cuff repair devices more

Histogenics Acquires ProChon Biotech in an All-Stock Transaction BY LAUREN UZDIENSKI, MAY 18, 2011

Histogenics acquired ProChon Biotech in an all-stock exchange this week, with the companies declining to announce a dollar amount for the transaction. Both companies are developing autologous cartilage regeneration products. more

Stryker to Acquire Orthovita for $316M BY LAUREN UZDIENSKI, MAY 16, 2011

Orthovita announced this morning that the company agreed to be acquired by Stryker for $3.85 per share in cash, which represents a 58% and 67% premium to the 30-day and 60-day volume weighted average stock prices. The total deal is valued at $316 million, which the company says is the "largest single upfront payment for an orthobiologics company." more

FDA Panel Narrowly Votes in Favor of BMTI's Augment BY LAUREN UZDIENSKI, MAY 12, 2011

It's been a roller coaster week for BioMimetic Therapeutics, with the stock dipping to a new 52-week low on Tuesday in response to an FDA summary of their Augment pivotal study. However, the week should end on a more positive note for the company, who received a cautious recommendation from a CDRH panel in favor of approval of Augment. more

Musculoskeletal News Roundup 12-May-11 BY LAUREN UZDIENSKI, MAY 12, 2011

DJO, Tornier, TSON announce earnings . . . OsteoGeneX receives grant funds . . . BMTI introduces new Augment kit size in Canada . . . Wright Medical commences full commercial launch of the INBONE II Total Ankle . . . Orthovita notes positive vertebroplasty coverage decision . . . RTI Biologics splits Chairman, CEO roles more

Metal-on-Metal Hips Under Fire as FDA Requests Post-Market Studies BY SANDER DUNCAN, MAY 11, 2011

The FDA has ordered all manufacturers of metal-on-metal hip implants to conduct studies of the devices. Metal-on-metal hips, once accounting for one-third of all artificial hips implanted annually in the United States, have come under fire recently following reports on high failure rates and increased wear debris. more

Medtronic Names New Chairman and CEO BY LAUREN UZDIENSKI, MAY 10, 2011

This morning Medtronic named Bill Hawkins' successor, appointing Omar Ishrak as the company's chairman and chief executive officer. more

Ahead of Thursday's Panel, FDA Voices Augment Concerns BY LAUREN UZDIENSKI, MAY 10, 2011

BioMimetic Therapeutics is facing some turbulence heading into its FDA panel meeting this week. The stock dove over 30% this morning on concerns about the Augment IDE study, detailed in the FDA's executive summary of the Augment PMA. more

WMGI's Compliance Issues Deepen as U.S. Attorney Alleges "Material Breach" of DPA BY LAUREN UZDIENSKI, MAY 6, 2011

Additional resignations and a letter from the U.S. Attorney's Office alleging a "material breach" of Wright Medical's Deferred Prosecution Agreement are further clouding the company's compliance issues. Wright Medical disclosed on Wednesday afternoon that three executives resigned "without good reason," a month after CEO Gary Henley resigned and SVP and CTO Frank Bono was terminated. The letter from the USAO arrived on Thursday morning, according to the company's 1Q:11 press release. more

Musculoskeletal News Roundup 5-May-11 BY LAUREN UZDIENSKI, MAY 5, 2011

ATEC, ANIK, ARTC, EXAC, NUVA, OFIX, SNN, WMGI and more report 1Q:11 . . . Bacterin, BioPoly and Nextremity Solutions announce funding rounds . . . TiGenix provides reimbursement updates for Belgium and the Netherlands . . . Zimmer launches UniWallis . . . Management changes at TiGenix more

Senator Questions Medtronic Over Canceled GPO Contracts BY LAUREN UZDIENSKI, MAY 4, 2011

When Medtronic canceled certain contracts with GPOs Novation in Premier back in March, they alleged that ending these relationships would save the company money. Now the government is worried that move will cost Medicare money, and Senate finance committee chairman Max Baucus has announced plans to investigate the company's choice to cancel what was reportedly $2 billion in contracts with Novation and Premier. more

New Diagnostic Can Show Implants at Risk for Failure BY LAUREN UZDIENSKI, MAY 3, 2011

Researchers at the University of Nebraska Medical Center and the Hospital for Special Surgery have collaborated to develop a polymer-based contrast agent that can identify inflammation that may predict implant failure in joint replacement patients. more

In the Wake of the Synthes Deal, Zimmer Speaks to Growth Strategy BY LAUREN UZDIENSKI, MAY 2, 2011

Last week's announcement that J&J would acquire Synthes has fueled speculation about which deals might be next as manufacturers strive to stay competitive as DePuy expands its reach. Several reports have referenced ongoing rumors that Smith & Nephew is a prime candidate to be taken private, and Zimmer and Stryker have been identified as potentially on the lookout for new transactions. Could the Synthes deal be setting the stage for a new wave of consolidation in the orthopedics industry? more


Complete Archive